Litigation for Patent RE38,551

✉ Email this page to a colleague

▶ Start for $1
Remove trial restrictions

Subscribe to access the full database, or Try a Trial
Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
RE38,551	See Plans and Pricing	See Plans and Pricing	2013-07-10	2016-09-02	35:271 Patent Infringement	District Court, D. Delaware	None	See Plans and Pricing
RE38,551	See Plans and Pricing	See Plans and Pricing	2013-07-10	2014-06-23	35:271 Patent Infringement	District Court, D. Delaware	Defendant	See Plans and Pricing
RE38,551	UCB Inc. v. Ranbaxy Laboratories Ltd.	See Plans and Pricing	2013-07-10	2014-03-18	35:271 Patent Infringement	District Court, D. Delaware	None	See Plans and Pricing
RE38,551	See Plans and Pricing	See Plans and Pricing	2016-06-17	2018-10-17	35:271 Patent Infringement	District Court, D. Delaware	None	See Plans and Pricing
RE38,551	See Plans and Pricing	See Plans and Pricing	2016-06-17	2018-09-20	35:271 Patent Infringement	District Court, D. Delaware	None	See Plans and Pricing
>Patent	>Case Name	>Docket	>Date Filed	>Date Terminated	>Cause	>Court	>Jury Demand	>Link To Docket

Subscribe to access the full database, or Try a Trial
Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
RE38,551	ACTAVIS, INC.	See Plans and Pricing	2014-07-10	07-10-2014	Research Corporation Technologies, Inc.	Inter partes review	See Plans and Pricing	01-09-2015	Harold Kohn	See Plans and Pricing
RE38,551	Argentum Pharmaceuticals LLC	See Plans and Pricing	2015-11-23	11-23-2015	Research Corporation Technologies, Inc.	Inter partes review	See Plans and Pricing	05-23-2016	Harold Kohn	See Plans and Pricing
RE38,551	Mylan Pharmaceuticals Inc.	See Plans and Pricing	2016-05-25	05-25-2016	Research Corporation Technologies, Inc.	Inter partes review	See Plans and Pricing	10-24-2016	Harold Kohn	See Plans and Pricing
RE38,551	Breckenridge Phamaceutical, Inc.	See Plans and Pricing	2016-06-21	06-21-2016		Inter partes review	See Plans and Pricing	10-24-2016	Harold Kohn	See Plans and Pricing
RE38,551	Alembic Pharmaceuticals, Ltd.	See Plans and Pricing	2016-06-22	06-22-2016		Inter partes review	See Plans and Pricing	10-24-2016	Harold Kohn	See Plans and Pricing
>Patent	>Petitioner	>Status	>Filing Date	>Accorded Filing Date	>Patent Owner	>Trial Type	>Trial Number	>Decision Date	>Inventor	>Document Download